Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Drug interactions and oncological outcomes: a hidden adversary

Rachel P Riechelmann, Monika K Krzyzanowska

Published 28 Mar 2019

https://doi.org/10.3332/ecancer.2019.ed88

PDF

Precision oncology: as much expectations as limitations

Vitor Fiorin Vasconcellos, Leandro Machado Colli, Ahmad Awada, Gilberto de Castro Junior

Published 29 Nov 2018

https://doi.org/10.3332/ecancer.2018.ed86

PDF

Propranolol and breast cancer—a work in progress

Pan Pantziarka, Brad A Bryan, Sergio Crispino, Erin B Dickerson

Published 18 Jun 2018

https://doi.org/10.3332/ecancer.2018.ed82

PDF

Does the oncology community have a rejection bias when it comes to repurposed drugs?

Bishal Gyawali, Pan Pantziarka, Sergio Crispino, Gauthier Bouche

Published 16 Jan 2018

https://doi.org/10.3332/ecancer.2018.ed76

PDF

Risk assessment in clinical trials: it don’t mean an ethical thing if it ain’t got that probability ring!

T Patrick Hill

Published 3 Sep 2014

https://doi.org/10.3332/ecancer.2014.ed42

PDF

Recycling existing drugs for cancer therapy: delivering low cost cancer care

Pan Pantziarka, Linda Cairns

Published 10 Jul 2014

https://doi.org/10.3332/ecancer.2014.ed40

PDF

An argument for discovery-driven research: from physicist to cancer researcher

Michael Retsky

Published 3 Jul 2014

https://doi.org/10.3332/ecancer.2014.ed38

PDF

International Clinical Trials Day 2014—ancient and modern needs

Francesco Perrone

Published 20 May 2014

https://doi.org/10.3332/ecancer.2014.ed35

PDF

The difficulties in cancer treatment

Sajib Chakraborty , Taibur Rahman

Published 14 Nov 2012

https://doi.org/10.3332/ecancer.2012.ed16

PDF

More from ecancer